SBC Medical Group Holdings Incorporated
NASDAQ•SBC
CEO: Dr. Yoshiyuki Aikawa
Sector: Industrials
Industry: Consulting Services
Listing Date: 2022-09-26
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.
Contact Information
Market Cap
$295.17M
P/E (TTM)
7.2
20.4
Dividend Yield
--
52W High
$5.75
52W Low
$2.78
52W Range
Rank38Top 36.9%
4.3
F-Score
Modified Piotroski Analysis
Based on 3-year fundamentals
Average • 4.3 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2023-2025
Financial Dashboard
Q1 2026 Data
Revenue
$43.06M+0.00%
4-Quarter Trend
EPS
$0.11+0.00%
4-Quarter Trend
FCF
$8.68M+0.00%
4-Quarter Trend
2025 Q3 Earnings Highlights
Key Highlights
Q3 Net Income Surge Net income attributable to SBC was $12.82B USD for the three months ended Sep 30, 2025, marking a 352.70% increase.
Strong Cash Position Maintained Cash and cash equivalents totaled $127.43B USD as of September 30, 2025, slightly up from $125.04B USD at year-end 2024.
Rental Revenue Growth Strong Rental services revenue increased 50.79% Q3 to $6.22B USD, driven by opening new clinics and equipment demand.
Risk Factors
Overall Revenue Decline Noted Total revenues for nine months fell 16.74% to $134.04B USD, primarily due to franchising fee structure revisions.
Negative Operating Cash Flow Net cash used in operating activities was $(27.30B) USD for nine months, a significant reversal from $27.89B provided in 2024.
Control Weaknesses Remain Unremediated Disclosure controls were not effective as of September 30, 2025; previously identified material weaknesses remain un-remediated.
Outlook
Waqoo Acquisition Moving Forward Board approved tender offer for Waqoo, aiming for consolidation to accelerate R&D and integrate advanced technologies.
Capital Deployment Flexibility Company evaluates capital deployment options including dividends and stock repurchases while pursuing growth investments.
Ongoing Internal Control Focus Management remains committed to ongoing improvements in disclosure controls and internal control over financial reporting execution.
Peer Comparison
Revenue (TTM)
$4.13B
$3.16B
$2.26B
Gross Margin (Latest Quarter)
88.9%
69.8%
42.0%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| SB | $705.49M | 18.3 | 4.7% | 38.5% |
| ASC | $696.91M | 11.9 | 9.0% | 13.3% |
| SPIR | $593.14M | 12.5 | 0.2% | 4.3% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-0.2%
Flat Growth
4Q Net Income CAGR
66.3%
Profitability Improved
Cash Flow Stability
50%
Cash Flow Needs Attention
Deep Research
Next earnings:Aug 12, 2026
EPS:$0.12
|Revenue:$45.37M
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data